Aurora Investment Counsel Regeneron Pharmaceuticals, Inc. Transaction History

Aurora Investment Counsel

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 24, 2020	SELL	$493.32 - $643.92 $326,577 - $426,275	-662 Closed	0 $0
Q1 2020 Apr 21, 2020	SELL	$336.18 - $494.43 $791,367 - $1.16 Million	-2,354 Reduced 78.05%	662 $323,000
Q4 2019 Feb 27, 2020	SELL	$274.13 - $376.51 $536,472 - $736,830	-1,957 Reduced 39.35%	3,016 $1.13 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $43,480 - $50,624	159 Added 3.3%	4,973 $1.38 Million
Q2 2019 Aug 06, 2019	BUY	$299.6 - $414.82 $426,330 - $590,288	1,423 Added 41.96%	4,814 $1.47 Million
Q1 2019 Apr 17, 2019	BUY	$372.08 - $439.57 $1.26 Million - $1.49 Million	3,391 New	3,391 $1.39 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.